PlainRecalls
FDA Drug Moderate Class II Terminated

GLYBURIDE and METFORMIN HYDROCHLORIDE Tablets USP, 5mg/500mg, 500 count bottle, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC: 0093-5712-05

Reported: May 21, 2014 Initiated: March 24, 2014 #D-1293-2014

Product Description

GLYBURIDE and METFORMIN HYDROCHLORIDE Tablets USP, 5mg/500mg, 500 count bottle, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC: 0093-5712-05

Reason for Recall

CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
2532 bottles
Distribution
Nationwide
Location
Horsham, PA

Frequently Asked Questions

What product was recalled?
GLYBURIDE and METFORMIN HYDROCHLORIDE Tablets USP, 5mg/500mg, 500 count bottle, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC: 0093-5712-05. Recalled by Teva Pharmaceuticals USA. Units affected: 2532 bottles.
Why was this product recalled?
CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements
Which agency issued this recall?
This recall was issued by the FDA Drug on May 21, 2014. Severity: Moderate. Recall number: D-1293-2014.